[HTML][HTML] Human papillomavirus vaccines: an updated review

L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

[HTML][HTML] An update on human papilloma virus vaccines: history, types, protection, and efficacy

Z Yousefi, H Aria, F Ghaedrahmati, T Bakhtiari… - Frontiers in …, 2022 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide.
Early prevention with HPV vaccination is a safe and effective method against this disease …

Combination of a cationic complexes loaded with mRNA and α-Galactose ceramide enhances antitumor immunity and affects the tumor immune microenvironment

J Guo, S Ma, Y Mai, T Gao, Z Song, J Yang - International …, 2022 - Elsevier
Abstract mRNA vaccination is considered to be a promising strategy for tumor
immunotherapy. Among, adequate antigen expression and regulation of tumor immune …

[HTML][HTML] Role of Epstein-Barr virus and human papillomavirus coinfection in cervical cancer: epidemiology, mechanisms and perspectives

R Blanco, D Carrillo-Beltrán, JC Osorio, GM Calaf… - Pathogens, 2020 - mdpi.com
High-risk human papillomavirus (HR-HPV) is etiologically associated with the development
and progression of cervical cancer, although other factors are involved. Epstein-Barr virus …

Mannose-modified liposome co-delivery of human papillomavirus type 16 E7 peptide and CpG oligodeoxynucleotide adjuvant enhances antitumor activity against …

Y Zhao, H Wang, Y Yang, W Jia, T Su… - International Journal …, 2020 - Taylor & Francis
Background Previously, we demonstrated the therapeutic efficacy of a human
papillomavirus (HPV) vaccine, including HPV16 E7 peptide and CpG oligodeoxynucleotides …

[HTML][HTML] Human papillomavirus (HPV) vaccine knowledge, awareness and acceptance among dental students and post-graduate dental residents

SK Mann, K Kingsley - Dentistry Journal, 2020 - mdpi.com
Introduction: The recent development of a vaccine that is highly effective against the human
papillomavirus (HPV) has been met with widespread clinical and public health professional …

Expanded Programme on Immunization at 50 years: its legacy and future

B Wahl, VE Pitzer - Lancet (London, England), 2024 - pubmed.ncbi.nlm.nih.gov
Expanded Programme on Immunization at 50 years: its legacy and future Expanded
Programme on Immunization at 50 years: its legacy and future Lancet. 2024 May 25;403(10441):2265-2267 …

[HTML][HTML] Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker

L Li, Y Tong, J Wu, X Xu - Cancer Cell International, 2023 - Springer
Cervical cancer is a leading cause of gynecological cancer death in the world. Human
papillomavirus (HPV) is the most causative factor of cervical cancer. In addition, many …

High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis

M Caicedo-Martínez… - … journal of STD & …, 2021 - journals.sagepub.com
We carried out a systematic review to summarize available data regarding prevalence of
high-risk human papillomavirus (HR-HPV) among women living with HIV (WLHIV) in Latin …

Znanje i mišljenja djelatnica Srednje škole Bedekovčina i Srednje škole Pregrada o značaju redovitih ginekoloških pregleda

K Zebec - 2023 - zir.nsk.hr
Sažetak Cilj istraživanja: Cilj istraživanja je analizirati znanje i stavove ispitanica o redovitim
ginekološkim pregledima te istražiti povezanost između njihovih sociodemografskih …